Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

BRIEF

published on 06/10/2024 at 15:20, 5 months 10 days ago

Adolore BioTherapeutics fera une présentation à la conférence virtuelle de présentation des investisseurs

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Conférence Virtuelle De Présentation Des Investisseurs Sans Opioïdes
PRESS RELEASE

published on 06/10/2024 at 15:15, 5 months 10 days ago

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
Adolore BioTherapeutics to present at Virtual Investor Pitch Conference on June 17, 2024, 10:00 AM ET. CEO Roelof Rongen to provide an elevator pitch on breakthrough opioid-free gene therapy treatments for chronic pain

Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy Virtual Investor Pitch Conference
BRIEF

published on 05/21/2024 at 16:05, 5 months 30 days ago

Adolore BioTherapeutics Unveils Strategy for Non-Opioid Analgesic Gene Therapies

Adolore BioTherapeutics Chronic Pain Gene Therapy Clinical Studies Non-opioid Analgesic
BRIEF

published on 05/21/2024 at 16:05, 5 months 30 days ago

Adolore BioTherapeutics dévoile sa stratégie pour les thérapies géniques analgésiques non opioïdes

Adolore BioTherapeutics Thérapie Génique Études Cliniques La Douleur Chronique Analgésique Non Opioïde
PRESS RELEASE

published on 05/21/2024 at 16:00, 5 months 30 days ago

Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the Treatment of Chronic Pain
Adolore BioTherapeutics outlines pipeline development progress and business outlook focused on breakthrough gene therapy treatments for chronic pain, funded by NIH grant

Adolore BioTherapeutics Chronic Pain Gene Therapy Pipeline Development NIH Grant
BRIEF

published on 05/16/2024 at 16:05, 6 months 4 days ago

Adolore BioTherapeutics fait progresser le traitement de la douleur chronique non opioïde

Thérapie Génique Traitement De La Douleur Chronique Soulagement De La Douleur Non Opioïde Canaux Potassiques Kv7 Avancées De La Biotechnologie
BRIEF

published on 05/16/2024 at 16:05, 6 months 4 days ago

Adolore BioTherapeutics Advances Non-Opioid Chronic Pain Therapy

Gene Therapy Chronic Pain Treatment Non-Opioid Pain Relief Kv7 Potassium Channels Biotechnology Advancements
PRESS RELEASE

published on 05/16/2024 at 16:00, 6 months 4 days ago

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRIEF

published on 03/04/2024 at 16:05, 8 months 16 days ago

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRIEF

published on 03/04/2024 at 16:05, 8 months 16 days ago

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 8 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 8 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 38 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 5 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 8 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 33 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 53 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 1 minute ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 8 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 38 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 48 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE